Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ALGXY NASDAQ:DKDCA OTCMKTS:RPBC OTCMKTS:VRACY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALGXYAffinity Energy and Health$0.00$0.00▼$0.26N/A135.11800 shsN/ADKDCAData Knights Acquisition$0.55-9.6%$0.45$5.00▼$13.51$2.85M0.1839,705 shs145,803 shsRPBCRedpoint Bio$0.00+∞$0.00$0.00▼$0.00N/AN/A101,150 shs200,000 shsVRACYViralytics$3.75$0.00$1.50▼$4.10N/AN/A247 shsN/A5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALGXYAffinity Energy and Health0.00%0.00%0.00%0.00%0.00%DKDCAData Knights Acquisition0.00%-0.63%+42.54%+3.55%-44.42%RPBCRedpoint Bio0.00%0.00%0.00%0.00%0.00%VRACYViralytics0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALGXYAffinity Energy and HealthN/AN/AN/AN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ARPBCRedpoint BioN/AN/AN/AN/AN/AN/AN/AN/AVRACYViralyticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALGXYAffinity Energy and Health 0.00N/AN/AN/ADKDCAData Knights Acquisition 0.00N/AN/AN/ARPBCRedpoint Bio 0.00N/AN/AN/AVRACYViralytics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALGXYAffinity Energy and Health$2.05MN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/A$0.00 per share111.42($1.82) per shareN/ARPBCRedpoint BioN/AN/AN/AN/AN/AN/AVRACYViralyticsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALGXYAffinity Energy and Health-$6.08MN/A0.00N/AN/AN/AN/AN/AN/ADKDCAData Knights Acquisition$340K-$0.19N/A∞N/AN/AN/A-5.55%N/ARPBCRedpoint BioN/AN/A0.00∞N/AN/AN/AN/AN/AVRACYViralyticsN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALGXYAffinity Energy and HealthN/AN/AN/AN/AN/ADKDCAData Knights AcquisitionN/AN/AN/AN/AN/ARPBCRedpoint BioN/AN/AN/AN/AN/AVRACYViralyticsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALGXYAffinity Energy and HealthN/ADKDCAData Knights Acquisition35.35%RPBCRedpoint BioN/AVRACYViralyticsN/AInsider OwnershipCompanyInsider OwnershipALGXYAffinity Energy and HealthN/ADKDCAData Knights Acquisition45.72%RPBCRedpoint Bio11.51%VRACYViralyticsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALGXYAffinity Energy and HealthN/AN/AN/ANot OptionableDKDCAData Knights Acquisition25.17 million2.81 millionNot OptionableRPBCRedpoint BioN/AN/AN/ANot OptionableVRACYViralyticsN/AN/AN/ANot OptionableVRACY, ALGXY, RPBC, and DKDCA HeadlinesRecent News About These CompaniesOncolytics: the dawn of a new era in cancer treatmentOctober 17, 2024 | pharmaphorum.comPViralytics lifted by FDA panel verdict on T-VecSeptember 6, 2024 | pharmaphorum.comPBig pharma could turn to viruses to boost cancer immunotherapiesAugust 16, 2024 | pharmaphorum.comPReflection and refraction of light - CCEAMay 27, 2024 | bbc.co.ukBridgewater founder Ray Dalio warns of danger of US debt to Treasury marketMay 18, 2024 | ft.comViewRay, Inc. (VRAY)April 22, 2024 | finance.yahoo.com50% Off Ray-Ban Promo Codes - MarchMarch 20, 2024 | latimes.comWhat is Billy Ray Cyrus' net worth?March 6, 2024 | celebritynetworth.comCThe best 4K Blu-ray players 2024: Ultra HD marvels chosen by our expertsMarch 3, 2024 | techradar.comTThe Ray D'Arcy ShowFebruary 13, 2024 | rte.ieRDistrict Attorney Once Linked To Jerry Sandusky Investigation Disappears: "It’s Truly Like He Did Vanish Into Thin Air"February 5, 2024 | oxygen.comORay, MI Weather ConditionsFebruary 1, 2024 | wunderground.comWTo Inhibit or Not to Inhibit MEK With BRAF Inhibitors: Is That the Question?January 5, 2024 | ascopubs.orgARay Romano Explains Why an ‘Everybody Loves Raymond’ Reboot Is ‘Out of the Question'December 20, 2023 | mensjournal.comMoncolytic virusDecember 15, 2023 | pharmaphorum.comPRachael Ray Cookware ReviewsDecember 14, 2023 | consumeraffairs.comCRay Anderson out at Arizona State? Good luck to whoever's nextNovember 25, 2023 | azcentral.comALenses and ray diagrams - OCR GatewayNovember 25, 2023 | bbc.co.ukArizona State Athletic Director Ray Anderson resignsNovember 24, 2023 | azcentral.comATop broker names 3 healthcare shares to buyOctober 27, 2023 | fool.com.auMedia Sentiment Over TimeVRACY, ALGXY, RPBC, and DKDCA Company DescriptionsAffinity Energy and Health OTCMKTS:ALGXYAffinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.Data Knights Acquisition NASDAQ:DKDCA$0.55 -0.06 (-9.59%) As of 07/14/2025Data Knights Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. Data Knights Acquisition Corp. was incorporated in 2021 and is based in Frome, the United Kingdom.Redpoint Bio OTCMKTS:RPBC$0.0001 +0.00 (+∞) As of 07/23/2019Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.Viralytics OTCMKTS:VRACYViralytics Limited, a biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies in Australia and internationally. The company's lead investigational product is CAVATAK, a proprietary formulation of an oncolytic common cold virus that is in Phase Ib clinical trials for the treatment of melanoma, and lung and bladder cancer; Phase II clinical trials for the treatment of late stage melanoma; and in pre-clinical studies for the treatment of prostate and breast cancer, multiple myeloma, pancreatic cancer, malignant glioma, acute myeloid leukemia, and chronic lymphocytic leukemia. It is also developing EVATAK to treat ovarian, prostate, and gastric cancer. The company was formerly known as Psiron Ltd. and changed its name to Viralytics Limited in December 2006. Viralytics Limited is headquartered in Sydney, Australia. As of June 20, 2018, Viralytics Limited operates as a subsidiary of Merck Sharp & Dohme (Holdings) Pty Ltd. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
